Cervical spondylosis lumbar disc herniation knee osteoarthritis
Conditions
Interventions
treatment group:JinBi Granules+Capsule analogue
control group:The placebo particles+Celebrex capsules
Sponsors
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. To meet the diagnostic criteria and TCM syndrome patients; 2. voluntarily in patients undergoing treatment plan of this research; 3. Aged 40-65 years old; 4. Agree and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. the associated with cardiovascular disease and mental illness, suspected in patients with a history alcohol and drug abuse; 2. imaging studies have complicated disease such as fracture, bone disease patients; 3. accompanied by cervical spinal cord compression syndrome, particularly intense pain associated with cauda equina syndrome, severe knee instability and form; 4. received other treatment, may affect this study treatment effect index observation of patients; 5. patients with skin diseases and infectious diseases; 6. Was known for "celebrex" or the ingredient allergies; 7. Pet-name ruby pregnancy women; 8. Attending other reasons should not or cannot be applied to the treatment of patients; 9. A history of peptic ulcer; 10. The function of liver and kidney abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogus scale;Neck Disability Index;Lumbar Disability Index;WOMAC osteoarthritis index survey;SF - 36 life quality score; | — |
Countries
China
Contacts
Public ContactJie Ye
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed